In the research conducted by Huguenard et al., the plasma levels of L-carnitine, its metabolites γ-butyrobetaine and Trimethylamine-N- oxide (TMAO), and its esters (acylcarnitines) were examined in the APOE ε4- pre-clinical MCI/AD + MCI group. Here, APOE is linked to Alzheimer disease.